Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | D3L-001 |
Trade Name | |
Synonyms | D3L 001|D3L001 |
Drug Descriptions |
D3L-001 is a bispecific antibody targeting ERBB2 (HER2) and CD47, which potentially inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 1873). |
DrugClasses | CD47 Antibody 31 HER2 (ERBB2) Antibody 76 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
D3L-001 | D3L-001 | 0 | 1 |